Strategy Driven

JULY 13, 2011

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). Copyright (c) 2011. Copyright 2007-2011 by StrategyDriven, Inc.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

MARCH 2, 2011

Undertakings with $20 million price tags such as the post-merger integration of a giant pharmaceutical client and its equally humongous acquisition. The most intense competition between consulting firms is for "whale" engagements. Or redesigning a company's entire store system and approach to customers.

Consultative 15

Consultative Strategy McKinsey Porter 15

QAspire

JANUARY 24, 2010

He was a marketing executive with a large pharmaceutical company when he decided to pursue his calling and start a fitness center. “ You get almost nothing without going through some kind of pain, unless you win a lottery.”, replied the man who was himself a fitness freak. He neither had space nor money to start out.

Directory 84

Directory Blog Pharmaceuticals Quality 84

The Recovering Engineer

FEBRUARY 27, 2010

There are parts of the problem that aren’t addressed by the health care bills under consideration (most egregiously the ridiculous prices charged for pharmaceuticals), but all of the parts being addressed are parts of the problem, while the quality of care itself frankly isn’t.

Health Care 102

Health Care Engineering System Politics 102

The Recovering Engineer

FEBRUARY 27, 2010

There are parts of the problem that aren’t addressed by the health care bills under consideration (most egregiously the ridiculous prices charged for pharmaceuticals), but all of the parts being addressed are parts of the problem, while the quality of care itself frankly isn’t.

Health Care 102

Health Care Engineering System Politics 102

Harvard Business Review

APRIL 16, 2014

That is perhaps the most frequent question I’ve received since 2011 when GlaxoSmithKline changed the link between the bonus pay of our pharmaceutical sales professionals in the United States and the numbers of prescription sold for a particular medicine.

Incentives 13

Incentives Pharmaceuticals Health Care Metrics 13

Harvard Business Review

MAY 20, 2014

The rate of business formation in 2011 was almost half of what it was in 1978, with the rate of dissolution somewhat higher than the past couple decades. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. Consolidation of the financial sector has led to similar dynamics in other industries.

Pharmaceuticals 10

Pharmaceuticals Banking Chemicals Trends 10

Harvard Business Review

AUGUST 3, 2012

Although many analysts and even executives have stated that established pharmaceutical firms are cutting their R&D budgets, the fact is that ongoing R&D expenditures on internal projects remain just as high in 2011 and 2012 as they have for the past decade — and those levels are historical highs.

Licensing 13

Licensing Depreciation Pharmaceuticals Budgeting 13

Harvard Business Review

DECEMBER 12, 2012

Based on data covering the period from 2005 to 2011, it charts how globalization has evolved since the onset of the financial crisis at the global, regional, and national levels. We compare the depth and breadth of 20 industries' global connectedness before delving into three case studies: pharmaceuticals, passenger cars and mobile phones.

Report 15

Report Merchandising GDP Globalization 15

Harvard Business Review

DECEMBER 20, 2011

The two biggest product stories of 2011 were arguably Lipitor and the iPhone 4S. Throughout its history, Pfizer's biggest product and the biggest-selling branded drug in pharmaceutical industry history, has delivered some confounding strategic lessons. 30) of a blockbuster prescription drug. Lipitor's Long Good-bye.

Disintermediation 15

Disintermediation Industry Pharmaceuticals Price 15

Harvard Business Review

NOVEMBER 8, 2017

The rising flood of hardware, pharmaceuticals, and technical expertise from American manufacturers and hospital companies, which is connected to the needs of a growing number of hospitals, is also pushing many systems closer to the U.S. Over the same period, pharmaceutical exports have doubled. Insight Center. Transforming Health Care.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

FEBRUARY 15, 2012

While Guangdong's exports accounted for as much as 37% of China's exports by 2000, its share dropped to 28% in 2011. The province's exports growth rate, which was 26% in 2010, fell to 22% in the first nine months of 2011, and it has continued to decline ever since. Look at the data.

GDP 12

GDP Pharmaceuticals Long-term Globalization 12

Harvard Business Review

AUGUST 17, 2012

In the US, Cipla sells its products generic pharmaceutical companies such as Teva and Eagle. irketi in 2011 provided expansion in Turkey. It has also formed a partnership with the Clinton Foundation to distribute ARVs in Africa. Cipla is not a stranger to M&A either. laç Ticaret Anonim ?irketi

Company 11

Company Pharmaceuticals Business Model Fixed Costs 11

Harvard Business Review

JANUARY 12, 2011

A few years ago, pharmaceutical giant sanofi-aventis sponsored an anonymous, Web-based survey of 4,200 workers at four health care, transportation, and manufacturing companies. If you expect to burn the midnight oil in 2011, factor in time to get the sleep your body and brain need.

Cost 15

Cost Absenteeism Pharmaceuticals Survey 15

Harvard Business Review

JANUARY 26, 2011

Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. Daniela Saltzman is an MBA student at HBS, class of 2011. Stay tuned. Eccles is a professor of management practice at HBS.

Long-term 14

Long-term Sample Report Pharmaceuticals 14

Harvard Business Review

DECEMBER 27, 2016

A study published in 2011 examined CEOs in the top-100 best hospitals in USNWR in three key medical specialties: cancer, digestive disorders, and cardiovascular care. But we would argue that credibility may also be signaled to important external stakeholders — future employees, patients, the pharmaceutical industry, donors, and so on.

Management 15

Management 360-Degree Feedback Mayo Training 15

In the CEO Afterlife

JUNE 19, 2011

by John • June 19, 2011 • Life , Marketing , Strategy • 1 Comment. So do pharmaceutical giants Eli Lilly and Pfizer. June 21, 2011 at 5:57 pm. December 2011. November 2011. October 2011. September 2011. August 2011. April 2011. March 2011. February 2011.

Advice 147

Advice Marketing Marketing Strategy Brand 147

Harvard Business Review

MARCH 2, 2012

In 2011, 71% of HBS's new cases were written about foreign companies. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology. Nestle, Unilever, and Novartis have several business units based in the U.S.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Strategy Driven

MARCH 18, 2011

Copyright 2007-2011 by StrategyDriven, Inc. It divested a number of personal care and confectionary lines (e.g., Schick razors and Trident) and acquired other products (e.g., Purell) consistent with its chosen way to play. To learn more about Capabilities-Driven Strategy, click here. All rights reserved.

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

OCTOBER 3, 2013

Back in 2011, in Citrus Lane’s first six months, its small founding team worked in a house and ate lunch together every day around a big table. We studied how Wyeth, the large Pharmaceutical firm (now part of Pfizer) made dramatic improvements in cost and quality across its manufacturing operation. After raising $5.1

Pharmaceuticals 8

Pharmaceuticals Seminar Learning-by-Doing Open-book 8

Harvard Business Review

MAY 17, 2012

In 2011, Embrace piloted the product in India, where 1.2 Embrace has already negotiated partnerships with multinational pharmaceutical and medical device companies such as GE Healthcare. Most importantly, priced at approximately $200, the Embrace portable infant warmer costs merely 1 percent of what incubators in Western markets cost.

Incubator 11

Incubator Business Model Entrepreneur Cost 11

Harvard Business Review

DECEMBER 14, 2015

Chirag Patel, CEO of Amneal Pharmaceuticals and Ernst & Young 2011 Entrepreneur of the Year, credits meditation with helping him feel more connected to his clients. “In a business you start connecting to your customer as your family rather than merely a business transaction.”

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Terry Starbucker

SEPTEMBER 30, 2010

No, not the pharmaceutical kind. This pill is invisible, and sits on our bed stands every morning, waiting for us to pop it into our brain. I forgot to take my happy pills.

Pharmaceuticals 243

Pharmaceuticals Ethics Self-aware Blog 243

Harvard Business Review

JUNE 29, 2015

This is consistent with a 2011 article in the Journal of Finance, which also found that “patents of private equity-backed firms applied for in the years after the investment are more frequently cited.” All of this adds to the contentious debate over whether PE investors sacrifice long-term growth for short-term profit.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

JUNE 16, 2016

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. Draetta of IACS has found many of the same issues arise in pharmaceutical research. In 2011, he commissioned a report that called for an “innovation policy” rather than an “industrial policy.”

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

FEBRUARY 24, 2015

We are not saying that rapid ownership change is a requirement for business success—quite to the contrary, it is often a corollary.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. This lab isn't located in Bangalore or Hyderabad (where Dr Reddy's is headquartered) but in.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

SEPTEMBER 5, 2013

In 2011, Thierry Andretta, the CEO of French fashion company Lanvin, announced an initiative called "no email Wednesdays" because he thought people had stopped actually talking to each other.

Productivity 8

Productivity Products Peer Review Short-term 8

Eric Jacobson

JUNE 8, 2010

In its heyday, Marion had 3,400 employees with sales of nearly $1 billion and in 1989 merged with Merrell Dow Pharmaceuticals. The Kansas City Star newspaper recently featured a story about Marion Laboratories and its 60th anniversary. "Great Places To Work" Employee Perks New Book Shows You How To Set A Goal And Then Reac.

Mentor 56

Mentor Mission Statement Tips Open-book 56

Strategy Driven

JANUARY 24, 2011

It’s what I push my clients to focus on as they seek to improve organizational performance – and it’s the lens I urge all leaders to look through as they review 2010 and make their ‘business resolutions’ for 2011. Here are a few of this year’s headline makers and the lessons that can be learned from each of them.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

NOVEMBER 2, 2018

Workers’ increasing out-of-pocket costs are creating widespread discontent with the underlying costs of care — a problem largely driven by the high prices charged to private payers for health services and pharmaceuticals. Between 2011 and 2017, employees’ premiums and deductibles grew faster than their median income.

Health Care 8

Health Care Cost Insurance Price 8

Harvard Business Review

NOVEMBER 20, 2015

Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail. In 2011, Havens’ collaboration with IBM procurement paid off, winning Havens four significant projects.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

MARCH 4, 2011

And that should make it easier for IBM to sell the question-answering technology in hospitals, law firms, pharmaceutical labs, call centers, and every other area in which people are grappling with finding answers in ever larger sets of data. This kind of defensive analysis no doubt provided some comfort to the public.

Learning Curve 11

Learning Curve Pharmaceuticals Call Center Technology 11

Harvard Business Review

MAY 10, 2013

The pressure on the company by the investing community (among others) was so severe that it eventually split into two, Motorola Mobility and Motorola Solutions in January of 2011. Such a pattern is well established in the pharmaceutical industry as large established firms partner with smaller biotech firms.

Venture Capitalist 8

Venture Capitalist Restructuring Competitive Advantage Short-term 8

Harvard Business Review

NOVEMBER 21, 2013

Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. The Leahy-Smith America Invents Act was passed into law in 2011 and most of its provisions came into effect earlier this year. Different forms of intellectual property rights can be used to protect valuable information.

Intangible Assets 8

Intangible Assets Merchandising Innovation Pharmaceuticals 8

Harvard Business Review

JUNE 21, 2017

We decided to create a direct-to-patient initiative using Collective Impact, a framework for tackling social issues first articulated , in 2011, by John Kania and Mark Kramer. Given that other data-sharing efforts have been met with varying degrees of success, we knew that a novel approach was required to truly make progress.

Metrics 8

Metrics Health Care Learning-by-Doing Education 8

Harvard Business Review

SEPTEMBER 11, 2014

Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology. However, the technologies used to offer food or lodging have not changed dramatically over the years.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22